ABSTRACT During infection, Mycobacterium tuberculosis is exposed to a diverse array of microenvironments in the human host, each with its own unique set of redox conditions. Imbalances in the redox environment of the bacillus or the host environment serve as stimuli, which could regulate virulence. The ability of M. tuberculosis to evade the host immune response and cause disease is largely owing to the capacity of the mycobacterium to sense changes in its environment, such as host-generated gases, carbon sources, and pathological conditions, and alter its metabolism and redox balance accordingly for survival. In this article we discuss the redox sensors that are, to date, known to be present in M. tuberculosis, such as the Dos dormancy regulon, WhiB family, anti-σ factors, and MosR, in addition to the strategies present in the bacillus to neutralize free radicals, such as superoxide dismutases, catalase-peroxidase, thioredoxins, and methionine sulfoxide reductases, among others. M. tuberculosis is peculiar in that it appears to have a hierarchy of redox buffers, namely, mycothiol and ergothioneine. We discuss the current knowledge of their biosynthesis, function, and regulation. Ergothioneine is still an enigma, although it appears to have distinct and overlapping functions with mycothiol, which enable it to protect against a wide range of toxic metabolites and free radicals generated by the host. Developing approaches to quantify the intracellular redox status of the mycobacterium will enable us to determine how the redox balance is altered in response to signals and environments that mimic those encountered in the host.
Redox reactions are essential for life and play a role in both aerobic and anaerobic respiration. In aerobic microorganisms, the oxidants and reactive species are equalized by the antioxidants in order to maintain redox balance (1) . Mycobacterium tuberculosis is an obligate aerobe, although it has been demonstrated that it can survive for more than a decade in vitro under anaerobic conditions. In the macrophage and the lung of the host, M. tuberculosis is exposed to a range of complex environments which can profoundly influence the physiology, including the redox homeostasis, of the mycobacterium. Thus, it is likely that the mechanisms to maintain redox homeostasis in M. tuberculosis are vital in determining disease outcome. As in other bacteria, M. tuberculosis has developed pathways that monitor and respond to gaseous signals, such as NO, CO, and O 2 , and fluctuations in the intra-and extracellular redox status (2) (3) (4) . In this article, we will explore the physiology and genetics of redox homeostasis in mycobacteria by considering the in vivo environments to which M. tuberculosis is exposed, the sensors whereby mycobacteria discern an imbalance in the redox balance both endogenously and in the extracellular environment, mechanisms utilized by mycobacteria to respond to redox stress in order to maintain the intracellular redox balance, and the means currently used to measure the redox state in mycobacteria.
REDOX HOMEOSTASIS
Oxidation is defined as a gain of oxygen, loss of electrons, or loss of hydrogen, whereas reduction is described as a loss of oxygen, gain of electrons, or gain of hydrogen. Redox homeostasis refers to the maintenance of the overall net balance of oxidative and reductive capacity within a biological system such as a single cell, organ, or organism. This equilibrium is crucial to life and provides the necessary redox environment to effectively utilize the reducing energy generated by the catabolism of cellular substrates for anabolism of DNA, lipids, and proteins.
One approach to maintain redox balance within living systems is by making use of redox couples, which function as redox intermediaries (or "redox buffers"). Reduction potential is a thermodynamic property of a redox couple and a measure of the tendency of the oxidized moiety to acquire electrons and therefore be reduced (1) . The more positive the reduction potential of a redox pair, the greater the likelihood that the oxidized species will gain electrons and be reduced. Important redox couples for maintaining redox balance in living systems are NAD + /NADH (E 0′ = −316 mV), NADP + /NADPH (E 0′ = −315 mV), FAD/ FADH 2 (E 0′ = −219 mV), ferredoxin (Fd ox /Fd red , E 0′ = −398 mV), and glutathione disulfide (GSSG)/2 glutathione (GSH) (E hc = −250 mV [10 mM]) (1) . The intracellular redox potential of a microorganism can theoretically be measured by the summation of the reduction potentials and reducing capacities of all the various linked redox couples (5) . The reduction potential of these redox couples will be affected by the pH as well as the concentrations of the species that comprise the redox couple. The contribution of the redox couple (or reducing capacity) will be determined by how large the pool of the redox couple is for the redox buffering system of the cell.
However, Hansen et al. (6) demonstrated that protein thiols constitute a redox active pool in living cells that is just as essential as GSH, which is considered to be the major intracellular redox buffer in most bacteria (albeit not mycobacteria). Thus, determining the redox status of a bacterium would constitute measurement of all redox couples and protein thiols and their corresponding disulfides within the bacterium, which is probably technically impossible, because of the unknown redox couples. For this reason, quantification of a representative redox couple is used to infer changes in the redox environment. For example, the GSSG/2GSH redox couple is often used as an indicator of the status of the bacterial redox environment, except in mycobacteria (5) . Methods for measuring the relative redox environment in mycobacteria will be discussed later.
Imbalances in the redox environment in both M. tuberculosis and the host environment may serve as stimuli in the bacillus and trigger mechanisms, which result in persistence, dormancy, or reactivation. Throughout the course of infection, M. tuberculosis is exposed to a range of microenvironments, each with its own unique set of redox conditions. The ability of M. tuberculosis to evade the immune system and cause disease may in large part be due to its capacity, by mostly unknown mechanisms, to sense environmental changes such as host-generated gases, available carbon sources, and pathological conditions such as the hypoxic granuloma, and respond by altering its metabolism and redox balance. An understanding of redox homeostasis within M. tuberculosis is crucial because it may also help explain antimycobacterial drug efficacy, as isoniazid (INH) (7), ethionamide (ETA) (8) , and PA-824 (9) are prodrugs which require bioreductive activation to exert their antimycobacterial effects. Therefore, the efficacy of the regimen may be compromised due to changes in cellular redox status. Also, reductive stress, as measured by an increased NADH/NAD + ratio within Mycobacterium smegmatis and Mycobacterium bovis, was shown to lead to INH resistance (10) . Mutations in M. smegmatis type II NADH-menaquinone oxidoreductase (Ndh-2) increased NADH levels while reducing the frequency of INH-NAD (as well as ETA-NAD) adduct formation, which decreased its binding to InhA (10, 11) . Furthermore, mutations in mycothiol (the main redox intermediary of M. tuberculosis) biosynthetic enzymes in M. smegmatis decreased INH and ETA efficacy (12) . Thus far, few studies have examined the specific mechanisms of how M. tuberculosis maintains redox homeostasis in vivo and what role these mechanisms may play in drug efficacy. Such studies have the potential of providing insight into M. tuberculosis persistence as well as into the development of novel antimycobacterial intervention strategies.
OXIDATIVE STRESS
Oxidative stress can be defined as an imbalance in the redox environment in favor of prooxidants that is capable of causing damage to biological systems (1) . From the perspective of M. tuberculosis inside the human host, endogenous sources of oxidative stress include natural byproducts of aerobic respiration and the electron transport chain (ETC) where O 2 is consumed as the terminal electron acceptor. Exogenous factors inducing oxidative stress in M. tuberculosis comprise the immune response of the host in addition to factors generating oxidative stress in the host, such as cigarette smoke and indoor air pollution.
By far the largest source of oxidative stress to M. tuberculosis inside the host is caused by the respiratory burst of phagocytic cells such as resident alveolar macrophages and recruited polymorphonuclear neutrophils (PMNs) that phagocytose M. tuberculosis upon inhalation into the lungs. NADPH oxidase (NOX2) of phagocytic cells was the first enzyme discovered with the primary function of generating reactive oxygen species (ROS) directly rather than as an unwanted byproduct (13) . Once activated, NOX2 transports electrons from cytoplasmic NADPH in the phagocytic cells across the phagosomal membrane to oxygen to generate superoxide ion (equation 1):
Its activity is tightly controlled and dependent on the formation of a multiprotein complex composed of core and regulatory components. NOX2 is essentially a transmembrane electron bucket brigade that links the cytoplasmic electron donor, NADPH, with oxygen as the electron acceptor in the phagosomal lumen. Two superoxide ions can react in a dismutation reaction catalyzed by superoxide dismutase (SOD), resulting in production of hydrogen peroxide (H 2 O 2 ).
The activity of NOX2 leads to the formation of ROS, which is a collective term that refers to O 2 radicals such as O (14, 15) , which leads to the generation of NO from L-arginine (equation 2).
This NO then reacts with O
•− 2 generated by NOX2 and results in the formation of free radicals such as NO
• , NO The production of ROS/RNS by the host serves as the main microbicidal strategy for phagocytized bacteria; however, ROS/RNS can also be detrimental to the host by damaging DNA or peroxidation of lipids and proteins (1) . In immunocompetent individuals the generation of ROS/RNS by innate immune cells is relatively efficient at containing and killing M. tuberculosis as exemplified by the fact that only 5 to 10% of those newly infected with M. tuberculosis will go on to develop tuberculosis (TB) in their lifetime (16) .
REDOX ENVIRONMENT OF THE LUNG
The lung is the single organ of the human body that is solely dedicated to the uptake of atmospheric O 2 and the elimination of volatile metabolic waste products. Given this role and the lung's delicate architecture, which confers a vast surface area and blood supply, it is understandable that it is particularly susceptible to oxidative damage. Thus, redox homeostasis in the lung is of pivotal importance. An average healthy adult breathing at a typical resting rate of 16 breaths/min inhales and exhales approximately 11,500 liters of air each day. Because of anatomical dead space within the lung, twothirds of this volume (7,667 liters) takes part in gaseous exchange at the alveolar level (17) . The lung is exposed to the highest O 2 concentrations in the body, but it is able to respond to oxidizing conditions that would threaten its structural and functional integrity and thereby maintain its redox state. It is now widely appreciated that oxidative stress plays an important role in the pathogenesis of various lung disorders including COPD, asthma, acute respiratory distress syndrome, pulmonary fibrosis, and even lung cancers (18, 19) .
Antioxidants of the lung are crucial in maintaining redox balance and include GSH, ascorbate, β-carotene, albumin-SH, uric acid, superoxide dismutases, catalases, and peroxidases (20) . GSH is the most abundant antioxidant in the lung, with concentrations in the extracellular lining fluid reaching over 400 μM and cellular cytoplasmic concentrations of 5 mM. The GSH:GSSG ratio in lungs of healthy adults is 30:1 (−210 to −240 mV), which represents a large antioxidant buffering capacity (21) . Surprisingly, the most common risk factors for TB in decreasing order of population attributable risk-namely, malnutrition, indoor air pollution, smoking, heavy alcohol use, HIV infection, and diabetes-all induce decreased GSH levels in the lungs (18, 19, (21) (22) (23) (24) (25) . These disturbances in the redox state of the host lung may act as triggers for reactivation of dormant M. tuberculosis.
In adults, the lungs have a total alveolar surface area of about 70 m 2 , which is roughly the size of half of a tennis court. This large area is not homogenous and contains distinct geographical differences in ventilation and perfusion, resulting in regional blood oxygenation differences (17) . Using resected lung tissue, it was shown that samples from lesions classified as "open" (oxygen rich) yielded actively growing M. tuberculosis that were predominantly drug resistant. Bacterial colonies that were "resurrected" from "closed" (oxygen-poor) lesions exhibited delayed growth yet were drug sensitive despite being refractory to antituberculosis treatment within the lung (26) . These results indicated that M. tuberculosis drug resistance could be due in part to the variations in regional O 2 levels within the lung. The Wayne model of hypoxia gives further support for the role of variable O 2 levels in drug resistance by demonstrating that anaerobically exposed M. tuberculosis is a poor target for antimycobacterial drugs (27) .
The ventilation perfusion ratio in the upper lung is greater than in the lower and ventral lung, resulting in higher O 2 tensions in the upper lung. It is widely believed that the lung apices are the preferred niche of M. tuberculosis replication as an obligate aerobe because of this relative excess of O 2 (28) . However, in response to infection, the human immune system is able to wall off M. tuberculosis into granulomas that are most likely hypoxic and perhaps even anaerobic (29) . Redox-active dyes that are reduced at pO 2 lower than 10 mmHg have shown that similar granulomas in monkeys and guinea pigs are indeed hypoxic (30) . Clearly, more research is needed to elucidate the mechanisms employed by the "obligate aerobe" M. tuberculosis which enable its survival in such hypoxic conditions within the human host.
REDOX SENSORS OF M. TUBERCULOSIS
In order for M. tuberculosis to thrive as a pathogen it must be able to sense and adapt to the ever-changing redox stress that it experiences during the course of infection from its initial exposure to the lung alveoli, followed by the destructive effects of the phagocytes' respiratory burst, to the hypoxic environment of the granuloma. Furthermore, M. tuberculosis is exposed to anything a person inhales and thus possesses redox sensor systems that allow it to successfully navigate this dynamic redox landscape.
The DosR/S/T Dormancy Regulon
The DosR/S/T dormancy regulon is a "three-component" system that integrates two heme histidine kinase sensors, DosS and DosT, with a single response regulator, DosR. Briefly, DosS and DosT sense physiologically relevant gases by binding to O 2 , NO, and CO, allowing M. tuberculosis to sense its extracellular redox environment and relay these signals through DosR to coordinate the expression of crucial genes in the Dos regulon involved in the metabolic shift of M. tuberculosis to the persistent state (31) (32) (33) (34) (35) (36) .
WhiB family
Another known redox sensor system of M. tuberculosis includes the intracellular WhiB Fe-S cluster family of proteins, particularly WhiB3 (37, 38) . M. tuberculosis contains seven WhiB proteins (WhiB1 to 7). WhiB-like (Wbl) proteins are relatively small proteins (75 to 130 amino acids) found only in actinomycetes, and they contain a helix-turn-helix motif and four conserved cysteine residues that coordinate binding of the Fe-S cluster (39) . Wbl proteins have also been shown to play a role in pathogenesis and cell division in mycobacteria (38, 40) , in oxidative stress in Corynebacterium glutamicum (41) , and in antibiotic resistance in mycobacteria and Streptomyces (42) . Experimental studies illustrating the mechanistic basis for how these Wbl proteins sense and respond to signals to exert their effects are lacking. The expression profiles of all seven M. tuberculosis whiB genes after exposure to antibiotic and in vitro stress conditions provided insights into the biological function of the M. tuberculosis WhiB family (43) .
Using a two-hybrid screen, M. tuberculosis WhiB3 was shown to interact with RpoV (SigA, Rv2703) and play a role in virulence in mice and guinea pigs (40) . Interestingly, in this study, mice infected with M. tuberculosis ΔwhiB3 showed a significant increase in survival compared to wild-type infected mice, even though M. tuberculosis ΔwhiB3 did not have an in vivo growth delay and animals (mice and guinea pigs) infected with M. tuberculosis ΔwhiB3 had identical bacterial organ burdens when compared with those infected with wildtype M. tuberculosis. Later, it was demonstrated that WhiB3 plays a role in maintaining intracellular redox homeostasis through its 4Fe-4S cluster by regulating catabolic metabolism and polyketide biosynthesis in M. tuberculosis (38, 44) . The 4Fe-4S cluster of WhiB3 is crucial to its role as a redox sensor and has been shown to directly associate with NO and to be degraded by O 2 (38) . It was further demonstrated that M. tuberculosis utilizes WhiB3 to link sensed changes in the intracellular redox state to a metabolic switchover to preferred in vivo carbon sources, namely fatty acids, which are likely to be in abundance inside host macrophages and are widely accepted as a major source of carbon and energy during chronic infection. This WhiB3-induced metabolic shift in M. tuberculosis differentially modulates the synthesis and incorporation of propionate into the complex virulence polyketides, polyacyltrehaloses, sulfolipids, phthiocerol dimycocerosates, and the storage lipid, triacylglycerol (TAG), under defined redox conditions (44) . TAG production, which is under conditional WhiB3 control, is also induced on exposure to NO, CO, and hypoxia through the Dos dormancy system. Thus, TAG synthesis establishes a link between intracellular (WhiB3) and extracellular (Dos) redoxdependent signaling pathways (45) (46) (47) .
WhiB4 is has been implicated in the pathophysiology of M. tuberculosis. The transcription of WhiB4 is induced by nutrient starvation (48), long-term hypoxia (49) , oxidants such as cumene hydroperoxide and diamide, heat stress (30) , and infection of macrophages (50). However, whiB4 expression is reduced after treatment with 2.5% ethanol, which denatures proteins and disrupts the membrane, and SDS, which resembles the surfactants that M. tuberculosis might encounter early in infection (30) . WhiB4 was found to respond to O 2 and NO via its 4Fe-4S cluster, thereby functioning as a sensor of redox signals. Upon oxidation, the cysteine thiols in WhiB4 were oxidized to disulfide bonds that induced oligomerization, thereby enabling WhiB4 to bind to GC-rich sequences in DNA and repress transcription of WhiB4 while inducing the expression of antioxidant genes that were hyperinduced in M. tuberculosis ΔwhiB4. Hence, M. tuberculosis ΔwhiB4 demonstrated increased resistance to oxidative stress and enhanced survival in macrophages in comparison to the wild type (51) . Upon infection of guinea pigs, M. tuberculosis ΔwhiB4 showed hypervirulence in the lungs but was defective in disseminating to the spleen. Thus, WhiB4 appears to act as a redox sensor that activates a response to oxidative stress in M. tuberculosis by modulating growth, redox balance, and virulence in response to the enhanced antimycobacterial activity in macrophages (51) .
WhiB7 contributes to intrinsic drug resistance in M. tuberculosis by activating its own expression and that of many drug-resistance genes in response to antibiotics (42) . Transcription of WhiB7 is also activated by a diversity of stress conditions, such as nutrient starvation, entry into stationary phase, and heat shock (30) . Furthermore, in clinical isolates of M. tuberculosis, WhiB7 is highly induced soon after the infection of resting and activated murine macrophages, which may be due to the reductive stress from the accumulation of NADH/NADPH generated by the catabolism of host fatty acids in macrophages (44, 52) . It was found that combining reducing conditions with low concentrations of erythromycin synergistically increased WhiB7 transcription in M. tuberculosis (53) . This provided further support that activation of WhiB7 is linked to cell metabolism and activated by a reducing environment.
Anti-σ factors
Another type of oxidative stress experienced by mycobacteria is termed disulfide stress (54) and results from the unwanted formation of disulfide bonds. The cytoplasm of mycobacteria is a highly reduced environment, which maintains protein cysteines in their reduced thiol forms. Disulfide stress sensors exist in M. tuberculosis in the form of anti-σ factors. SigH and SigE are extracytoplasmic σ factors that are important for M. tuberculosis survival under conditions of oxidative stress (55, 56) . Although SigL does not appear to be required for adaptation to oxidative stress, it has been shown to be regulated by redox conditions and required for full virulence of M. tuberculosis in mice (57, 58) . All three of these σ factors are cotranscribed with genes that code for anti-σ factors, which specifically bind to and inhibit the σ factor-dependent transcription (58) (59) (60) . These anti-σ factors contain an HXXXCXXC motif called the ZAS (zinc-associated anti-σ factors) motif. The thiols of the cysteines in the conserved ZAS motif bind Zn 2+ under reducing conditions. Under conditions of oxidative stress, the thiols act as a redox switch by forming a disulfide bond, thereby releasing the zinc ion (61, 62) . This leads to a conformational change in the anti-σ factors and decreases their affinity for their respective Sig proteins, resulting in transcriptional activation.
MosR
Recently, a redox-dependent transcriptional repressor of M. tuberculosis belonging to the MarR family, termed MosR (Rv1049, M. tuberculosis oxidation-sensing regulator), was described (63) . In its reduced form, MosR binds DNA and represses transcription; however, upon oxidation a disulfide bond is formed between two cysteines in the N-terminus of the protein, causing a conformational change and its dissociation from DNA. MosR was previously shown to play a role in survival of M. tuberculosis in macrophages (64) . The DNA binding sequence of the regulator was identified and found in the promoter regions of narX, ndhA, and rv1050, a secreted putative oxidoreductase (63). It's likely that other similar disulfide stress sensors remain to be discovered in M. tuberculosis.
M. TUBERCULOSIS DEFENSE STRATEGIES AGAINST ROS AND RNS
To survive the robust oxidative response inside macrophages, M. tuberculosis must withstand ROS/RNS. The thick cell envelope, consisting of large amounts of the oxygen radical scavengers lipoarabinomannan and phenolic glycolipid I, confers a degree of intrinsic resistance to ROS (65, 66) . Similarly, sulfatides have been shown to ASMscience.org/MicrobiolSpectruminterfere with the oxidative killing mechanisms of macrophages (67) .
M. tuberculosis may also be capable of limiting its exposure to NO within the host and thus increasing its chance of survival. Activated macrophages containing live M. tuberculosis showed reduced iNOS recruitment to phagosomes compared to activated macrophages containing dead bacteria or latex beads (68, 69) . M. tuberculosis is also able to induce host expression of arginase-1 (Arg-1), an enzyme that competes with iNOS for its substrate, L-arginine, leading to an overall decrease of NO production (70, 71) . Virulence studies in mice with Arg-1-deficient macrophages produced higher NO levels and resulted in decreased lung bacterial loads of M. tuberculosis (70) . It was also recently shown that Arg-1 is expressed in granuloma-associated macrophages and type II pneumocytes in human lung tissues from patients with TB (72) . The Arg-1-induced expression in human lungs of patients with TB may be a defensive strategy of M. tuberculosis to avoid lethal NO of the immune response.
Superoxide Dismutases
SODs are metalloproteins that catalyze the dismutation reaction of O •− 2 into H 2 O 2 and molecular O 2 . M. tuberculosis contains two SODs, SodA and SodC, which belong to Fe-SOD and the CuZn-SOD families, respectively (73, 74) . SodA is constitutively expressed in M. tuberculosis, indicating a role in detoxifying endogenous ROS, but its expression is increased under oxidative stress conditions (75) and nutrient starvation (48) . SodA is efficiently secreted by the SecA2 secretion machinery into the culture filtrate (76), and it has been associated with virulence because M. tuberculosis secretes ∼350-fold more enzyme than M. smegmatis (75) . SodC, on the other hand, contains a putative signal peptide, and its homologues in other pathogenic bacteria have been found either in the periplasmic space or anchored to the membrane (77) . In M. tuberculosis, using immunogold labeling, SodC has been shown to be located in the periphery of the bacilli (78) . SodC also promotes survival of M. tuberculosis in activated macrophages (79) .
Catalase-Peroxidase
Catalase-peroxidase (Kat) enzymes are hemoproteins that efficiently detoxify H 2 O 2 by converting it into water and oxygen (catalase function) and catalyze the conversion of alkyl peroxides (ROOR′) into their respective alcohols (peroxidase function) (80 (84, 85) . Furthermore, clinical isolates that were exposed to INH have higher levels of alkyl hydroperoxidases (AhpC) (86) .
Alkyl Hydroperoxidase
Peroxides, if left unchecked, could react with cellular components such as lipids and lead to the generation of highly reactive alkyl hydroperoxides (ROOH). AhpC is a non-heme peroxiredoxin containing three active cysteines that converts these reactive organic peroxides into their respective alcohol derivatives (87) . AhpC has also been demonstrated to confer protection against RNS by reducing peroxynitrite to nitrite (88) . Peroxiredoxin family reductases typically use reduced thioredoxin (Trx) to restore the catalytic activity of the reductase; however, M. tuberculosis Trxs are incapable of reducing AhpC (89) . Rather, M. tuberculosis AhpC forms a complex with dihydrolipoamide dehydrogenase (Ldp) and dihydrolipoamide succinyltransferase (SucB) via an adapter protein, AhpD, that reduces AhpC (90) . AhpD has a thioredoxin-like active site that is sensitive to lipoamide. Thus, it has been proposed that Lpd, SucB, AhpC, and AhpD form a NADH-dependent peroxidase and peroxynitrate reductase complex that strategically links the peroxidase activity of AhpC to the metabolic state of M. tuberculosis. Four other peroxiredoxins exist in M. tuberculosis, namely, AhpE, TPx, Bcp, and BcpB, and they utilize the traditional Trx to regenerate their reduced forms (91, 92) .
Thioredoxins
Thioredoxins (Trxs) are ubiquitous well-characterized low-molecular-weight (LMW) proteins that catalyze thiol-disulfide exchange reactions (93) . The redox active cysteines of Trxs are found in the conserved catalytic motif, WCXXC, and allow the proteins to function as disulfide reductases by cycling between a reduced dithiol form and an oxidized disulfide bond form (94) . The oxidized disulfide bond form of Trxs is reduced by the FAD-containing enzyme thioredoxin reductase (TrxR), which utilizes NADPH as an electron donor (95) . Trxs are important for maintaining a reducing cytoplasmic environment as well as supplying the source of reducing power for deoxyribonucleotide synthesis, sulfur assimi-lation, detoxification of ROS/RNS, protein repair, and redox regulation (96) .
M. tuberculosis contains three Trxs (TrxA, TrxB, and TrxC, with midpoint redox potentials of −248, −262, and −269 mV, respectively) that have all been shown to possess disulfide reductase activity using the insulin reduction assay, and one TrxR that was shown to reduce TrxB and TrxC only (97) 
Truncated Hemoglobins
Truncated hemoglobins (trHbs) are small heme-binding globin proteins that are widely found among bacteria, protozoa, and plants (98) . Based on the variability in the heme-binding pocket residues, trHbs have been divided into three groups, which share less than 30% sequence similarity with each other (98) . Putative physiological functions of trHbs include detoxification of ROS/RNS. M. tuberculosis has two trHbs called trHbN and trHbO that belong to group I and group II trHbs, respectively. M. tuberculosis trHbO reacts with H 2 O 2 and NO, suggesting a role in their detoxification (99) , while trHbN has potent NO oxidizing activity (100). The group II trHbs from Bacillus subtilis and Thermobifida fusca, which are very similar to M. tuberculosis trHbO, form high-affinity complexes with H 2 S (101). This may have physiological significance in thiol redox homeostasis in M. tuberculosis, which is known to produce H 2 S during cysteine metabolism (102) , but this remains to be investigated.
Methionine Sulfoxide Reductases
The atom within proteins that is most susceptible to oxidation is sulfur, in both cysteine and methionine residues (103) . Exposure to ROS and RNS, such as Snitrosothiols and nitrite, can lead to disulfide bonding (104) and methionine oxidation, probably through the formation of peroxynitrite (105) . The oxidation of methionine, whether in proteins or as a free amino acid, leads to two stereomeric forms of methionine sulfoxide: methionine S-sulfoxide and methionine R-sulfoxide. Most prokaryotes and eukaryotes express a family of methionine sulfoxide reductases (Msr) that reduce methionine sulfoxide to methionine using thioredoxin, thioredoxin reductase, and NADPH as the reducing system (106). Many organisms express at least one MsrA that acts on both peptidyl and free methionine S-sulfoxide and one or more MsrB isoforms that reduce peptidyl (but not free) methionine R-sulfoxide. M. tuberculosis expresses both MsrA (Rv0137c) (105) and MsrB (Rv2674) (107), each one stereospecific for one of the epimers of methionine sulfoxide. In contrast to other organisms, single Msr mutants in M. tuberculosis were no more susceptible to ROI or RNI than the wild type. Only an M. tuberculosis mutant deficient in both MsrA and MsrB was susceptible to hypochlorite and nitrite (107) . However, in contrast to the MsrA-deficient M. smegmatis (108), the dual-deficient mutant was not vulnerable to hydrogen peroxide and organic peroxides. This is possibly due to adaptations of the mycobacteria to the different oxidative environments in which the organisms reside. M. tuberculosis lives and persists in macrophage phagosomes, which have highly oxidative and nitrosative environments (109) .
THIOLS AS REDOX BUFFERS AND CELLULAR DETOXIFIERS
Most organisms use an LMW thiol/thiol disulfide reductase/NAD(P)H redox pathway to keep the cytoplasm in a reduced state (Fig. 1A) (110) (111) (112) (113) (114) (115) (116) . In this pathway, the LMW thiol (RSH) provides reducing equivalents (electrons) to cellular oxidants, reducing them and thereby rendering these oxidants unable to cause cellular damage. In doing this, the LMW thiol is oxidized to its corresponding disulfide (RSSR), which in turn, is cycled back to its reduced form by the NADPH-dependent flavoprotein disulfide reductase associated with the specific RSH/RSSR pair (Fig. 1B) . Apart from the reduction of oxidizing agents, RSHs are also capable of detoxifying (mopping up) the cell from a wide range of oxidants and toxins, including antibiotics, alkylating agents, and nitrogen species. These detoxifying pathways can either proceed via a direct reaction between the RSH and oxidant/toxin or be enzyme mediated through an RSHspecific S-transferase (117) (118) (119) (120) (121) (122) (123) . Although these RSHs are homologous in function, they are structurally diverse among the organisms in which they are produced and function in, as is evident from Fig. 1C .
Mycothiol

Mycothiol [1-D-myo-inosityl-2-(N-acetyl-L-cysteinyl)-amido-2-deoxy-α-D-glucopyranoside; MSH] is only produced in mycobacteria and other actinomycetes and
ASMscience.org/MicrobiolSpectrumserves as the major LMW thiol in most of these organisms (124) . MSH was first detected as an unknown thiol during the HLPC analysis of GSH-deficient Streptomyces cell extracts (125) . Its structure, which is unique when compared to the other LMW thiols, was elucidated shortly thereafter and consists of a central D-glucosamine moiety linked to myo-inositol through an α(1→1) glycoside bond to form a pseudodisaccharide. N-Acetylcysteine is bound to the D-glucosamine moiety through an amide bond to provide the biologically active thiol to the MSH structure (126) (127) (128) . For these reasons MSH, its related enzymes, and in vivo function have been the focus of numerous studies to determine, in most cases, if any of the MSH-related processes could provide suitable drug targets for new antitubercular drugs. In this regard, credit should be given to, among others, the Newton and Fahey, Steenkamp, Av-Gay, Jacobs, and Blanchard laboratories for their ground-breaking work in this area (124, 125, 127, 128, 131-134, 136-141, 146, 149-153, 158) .
Biosynthesis of mycothiol
MSH is synthesized by a pathway involving five enzymes. The biosynthesis of MSH is illustrated in Fig. 2A . Inositol-1-phosphate synthase (tbINO) catalyzes the formation of the MSH precursor, L-myo-inositol-1-phoshate (I-1-P), from glucose-6-phosphate (Glc-6-P). Although tbINO is not recognized as one of the MSH biosynthetic enzymes, it plays a vital role in the production of MSH and cell wall biosynthesis (129, 130) . In MSH biosynthesis, the glycosyltransferase MshA is responsible for the synthesis of 1-(D-myo-inosityl-3-phosphate)-2-acetamido-2-deoxy-α-D-glucopyranoside (GlcNAc-Ins-3P) by transferring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc (131, 132) . In the second step, MshA2, an as yet unidentified enzyme, catalyzes the dephosphorylation of GlcNAc-Ins-3-P to produce 1-D-myo-inosityl-2-acetamido-2-deoxy-α-D-glucopyranoside (GlcNAc-Ins) (132). GlcNAc-Ins is then deacetylized by the metal-dependent N-acetyl hydrolase, MshB, to produce 1-D-myo-inosityl-2-amino-2-deoxy-α-D-glucopyranoside (GlcN-Ins) as the third intermediate (133) (134) (135) . The ATP-dependent cysteine ligase, MshC, catalyzes the ligation of L-cysteine to GlcN-Ins through the formation of an amide bond to produce 1-D-myo-inosityl-2-(L-cysteinyl)-amido-2-deoxy-α-D-glucopyranoside (Cys-GlcN-Ins) in the penultimate step (136, 137) . In the final step, the acetyltransferase, MshD, transfers an acetyl group from the acetyl-CoA to Cys-GlcN-Ins, yielding MSH as the final product (138, 139) .
Although different homologues of the four identified biosynthetic enzymes (MshA, MshB, MshC, and MshD) have been characterized (134, 137, 140, 141) , MshA2 and its associated gene are still unidentified. The undiscovered phosphatase, MshA2, is crucial for the pathway to proceed to its final product (132) . Numerous putative inositol monophosphatases have been investigated as possible candidates for MshA2 activity without any success (142) (143) (144) (145) . Thus, it has been proposed that this enzyme activity might be shared by more than one enzyme (140).
Gene regulation and knockout studies of the MSH biosynthetic enzymes
Regulation of the expression of the MSH biosynthetic enzymes in mycobacteria is unknown (146) . In Streptomyces coelicolor, the production of MSH is under the control of a σ factor, σ R , which is regulated by the anti-σ factor RsrA (147) . RsrA has a thiol/disulfide redox switch, which when oxidized, releases σ R for mshA and mca (encoding for mycothiol-S-conjugate amidase [Mca]) gene activation. MSH is able to modulate the system: A decrease in intracellular MSH initiates σ R activation through the oxidation of RsrA. When MSH levels are restored, the oxidized RsrA is reduced by MSH and σ R is inactivated through RsrA binding. However, in mycobacteria, the σ R homologue does not regulate the MSH biosynthetic genes. This is indicative of a different regulation system in mycobacteria than that present in S. coelicolor. The mshA and mshD genes in M. tuberculosis are both directly downstream of putative transcription factors, Rv0485 and Rv0818, respectively (Fig.  2B) , which may be involved in MSH biosynthesis regulation (148) .
Numerous studies have investigated the effects of the knockouts of the MSH biosynthetic enzymes on the survival of different mycobacteria. Table 1 gives a brief overview of the major observations made during these studies. In M. smegmatis, chemically induced (149), transposon (131) , and single deletion mutants (150) of mshA proved to be nonessential for growth under normal laboratory conditions, although the mutants were more susceptible to some antibiotics and oxidative stress. Less than 0.4% of the total MSH detected in the wild-type strains was detected in these mutants. Mutations in M. smegmatis mshB had the least effect on MSH production, with the M. smegmatis mshB mutant able to produce up to 25% of the total MSH produced in the parent strain (150, 151) . A double mshB/mca M. smegmatis mutant showed a further decrease (<0.4% of the parent strain) in MSH levels, demonstrating that
Mca can compensate for MshB activity in the mshB mutants (150) . The mshB mutants were only slightly more susceptible to oxidative stress and the antibiotics tested than the wild type. The M. smegmatis mshC mutant was more susceptible to oxidizing agents and antibiotics than the M. smegmatis mshD mutant. Both of these mutants had reduced MSH levels-less than 5% and less than 0.4% of the parent strain MSH levels for the mshC and mshD mutants, respectively (150, 152, 153) . These studies also uncovered a link between MSH levels and M. smegmatis resistance to the prodrugs, isoniazid and ethionamide. Briefly, the lower the MSH levels in the mutant, the more resistant the mutant was to isoniazid and ethionamide relative to the parent strain. This suggests that MSH might be involved in the in vivo activation of these prodrugs (150, (154) (155) (156) .
In comparison with the studies in M. smegmatis knockout mutants, studies with the M. tuberculosis mycothiol biosynthetic enzyme knockout mutants displayed surprisingly different results. An M. tuberculosis Erdman mshA knockout mutant proved to be lethal, indicating the essential cellular function of MSH in M. tuberculosis (157) . An mshA mutant of M. tuberculosis H37Rv (158), also deficient in MSH, was able to grow in vitro in catalase-supplemented media and in vivo in immunocompromised and immunocompetent mice. This may be attributed to small but critical genetic differences between the two strains. The M. tuberculosis Erdman mshB mutant produced between 20 and 25% of MSH present in wild-type M. tuberculosis Erdman, and although it had increased sensitivity to rifampin, the mutant displayed otherwise normal growth under laboratory conditions (159) . Disruption of mshC in M. tuberculosis Erdman was also lethal (160) . The M. tuberculosis Erdman mshD mutant produced only 1% of the MSH present in the wild type and showed a heightened sensitivity to hydrogen peroxide (161) . This mutant also produced the novel thiol N-formyl-CysGlcN-Ins, which behaved as a weak substitute for MSH but was unable to support normal growth of the mutant under stressful conditions. The mshD mutant also demonstrated poor survival inside macrophages (161, 162) .
Mycothiol function and related enzymes
As stated previously, the major in vivo MSH function is to protect the cell against oxidative stress and toxins. When reacting with ROS, MSH is oxidized to mycothiol disulfide (mycothione, MSSM). The NADPH-dependent flavoprotein disulfide reductase (FDR), mycothiol disulfide reductase (Mtr), is responsible for recycling one equivalent of MSSM to two equivalents of MSH through the reduction of the MSSM disulfide bond (Fig. 3) (111,  163) . Mtr reduces the MSSM disulfide bond by a catalytic cycle similar to those of other FDRs such as GSH and trypanothione reductase (164) . When M. bovis BCG was treated with Mtr antisense oligonucleotides, there was a 66% reduction in growth of M. bovis BCG, demonstrating the essential nature of this enzyme (165) . MSH is also involved in the reduction of S-thiolated proteins through a pathway similar to the GSH/glutaredoxin (Grx) reduction pathway (Fig. 3) . The oxidoreductase mycoredoxin-1 (Mrx1), a Grx-like protein, is responsible for the reduction of protein S-mycothiolated mixed disulfides through the transfer of electrons from MSH to the mixed disulfide (166) . Van Laer and coworkers showed that oxidized Mrx1 (Mrx1 Ox ) can only be reduced back to reduced Mrx1 (Mrx1 Red ) by MSH with the formation of MSSM. An M. smegmatis Mrx1-deficient strain showed normal growth and a minor increase in hydrogen peroxide sensitivity when compared to the parent strain (166) .
MSH is also essential for various cellular detoxification pathways. The detoxification of NO and formaldehyde both involve the direct reaction of MSH with the 155 are more resistant to NO than MSH-deficient mutants and other GSH-producing bacteria (168) . The hemithioacetal S-hydroxymethyl-mycothiol (MSCH 2 OH) is formed from the direct reaction of MSH with formaldehyde. MSCH 2 OH is then oxidized by MscR in an NAD + -dependent reaction, at a rate 80 times slower than the MSNO reductase activity, to produce the MSH S-formyl thioester (MSCHO), which is subsequently hydrolyzed to produce MSH and formic acid (167) .
Another MSH-dependent detoxification pathway involves the formation of MSH S-conjugates of cellular toxins (alkylating agents [X-R], free radicals, and xenobiotics), followed by the cleavage of the MSH Sconjugate glycosaminyl-amide bond and transport of the mercapturic acid-labeled toxin (AcCys-R) from the cell (Fig. 3) . Mycothiol-S-transferase (MST) catalyzes the formation of the MSH S-conjugates (MS-R) (118), and Mca is responsible for the glycosaminyl-amide bond cleavage to produce the mercapturic acid-labeled toxin (AcCys-R) and GlcN-Ins, which is recycled back into the biosynthesis of MSH (169, 170) . Mca, found in all MSH-producing bacteria, is a close functional homologue of MshB and has been credited with the explanation of why MSH is still produced in MshB-deficient mycobacteria (151, 159) . Mca can also react with the MSH S-conjugates of various antibiotics, including cerulenin (170), rifamycin S (170, 171), streptomycin (171) , and neocarzinostatin (172) , to generate GlcN-Ins. The MSH S-conjugates of monobromobimane (a thiol-specific alkylating agent) and rifamycin S were shown to accumulate inside M. smegmatis mc 2 155 deficient of Mca activity, which was reversed after complementation of Mca activity (171) . The Mca-deficient mycobacteria were also more susceptible to rifamycin S and streptomycin, demonstrating that the Mca detoxification pathway plays a role in drug resistance of MSHproducing bacteria. This underscores the rationale of Mca being the focus of a number of inhibitor screening studies (173) (174) (175) (176) .
Intriguingly, a study also indicated that stationaryphase cultures of M. smegmatis mc 2 155, deficient in either MshA or MshC and therefore producing no MSH, were able to actively transport MSH from the culture media to generate levels of MSH inside the cell comparable to those of the wild type (177) . MSH itself also serves as a weak substrate for Mca (169, 178) and indicates the existence of a degradation pathway of MSH to produce N-acetylated cysteine (AcCys) and GlcN-Ins (170) (Fig. 3) . MSH isotopomers were used to determine the fate of the MSH catabolites GlcN-Ins and AcCys. It was found that GlcN-Ins either was catabolized further and metabolized by glycolysis and the Krebs cycle, or it was cycled back into the MSH biosynthetic pathway in the MshA-deficient mutants. AcCys was found to be deacetylated to cysteine and converted to pyruvate by a yet unknown cysteine desulfhydrase for metabolism by the Krebs cycle. Cysteine can also be converted to γ-glutamyl cysteine by γ-glutamyl cysteine synthetase (EgtA) for ergothioneine (ERG) biosynthesis (179) .
Ergothioneine
In 1909, Charles Tanret (180) isolated ERG (ergothioneine, 2-mercaptohistidine trimethylbetaine) (Fig. 1) from the ergot fungus, Claviceps purpurea, and its structure was elucidated in 1911 (180, 181) . ERG is synthesized not only in non-yeast fungi, but also in cyanobacteria (182) , mycobacteria (183) , and bacteria belonging to Actinomycetales (184) . It is also detected in mammalian cells and higher plant tissues (185, 186) , but there is no evidence to date for the direct biosynthesis of ERG in animals and plants, and it is understood to be acquired through diet (1) . ERG has drawn considerable interest due to its antioxidant properties, and many reports have shown that ERG may act as a cytoprotectant in vitro, but its role in vivo is uncertain.
Properties of ERG
ERG exists as a tautomer between its thiol and thione forms in solution, but it exists in its thione form at physiological pH (187) . However, the thione is in equilibrium with two resonance forms, EGT-b and EGTc, that are thiolate in character and contribute to the thiol-like activity of ERG (187) . ERG does not undergo auto-oxidation as readily as other thiols considered to be antioxidants, for example, GSH, which generates free radicals in the process (188, 189) . This stability of ERG accounts for its slow degeneration and its resistance to disulfide formation (185, 190) . Disulfide formation in ERG has been demonstrated at very low pH in the presence of copper and H 2 O 2 but not in alkaline or neutral solutions (191) . Seebeck (192) identified a putative five-gene cluster (Fig. 4B) for the biosynthesis of ERG in mycobacteria by identifying an S-adenosylmethionine (SAM)-dependent methyltransferase, an iron(II)-dependent oxidase, and a pyridoxal 5-phosphate-dependent β-lyase in M. avium that correspond to the homologous genes in organisms that produce ERG (e.g., Neurospora crassa) and are absent in nonproducers, such as Escherichia coli and B. subtilis. After cloning the corresponding genes for EgtB, EgtC, and EgtD in M. smegmatis and expressing them recombinantly in E. coli, in addition to using β-lyase from Erwinia tasmaniensis, in vitro reconstitution studies were used to verify that these enzymes did form part of the biosynthetic pathway of ERG in mycobacteria. Although awaiting genetic validation, the data suggested the following roles for the five Egt enzymes in the synthesis of ERG (Fig. 4A ): (i) EgtA, a γ-glutamyl cysteine synthetase, produces glutamyl cysteine, thought to be the sulfur donor; (ii) EgtB, a formylglycine-generating enzyme-like protein, is thought to catalyze the iron(II)-dependent oxidative sulfurization of hercynine; (iii) EgtC is a glutamine amidotransferase that catalyzes the hydrolysis of the γ-glutamyl amide bond in Intermediate 1; (iv) EgtD is a SAM-dependent methyltransferase that methylates histidine to form hercynine; and (v) EgtE is a pyridoxal 5-phosphatedependent β-lyase that removes pyruvate and ammonia from Intermediate 2 to generate ERG. Homologues of EgtD (histidine-specific methyltransferase) and EgtB [iron(II)-dependent enzyme that catalyzes the sulfurization of hercynine] are often encoded by genes that are adjacent in prokaryotes, including many mycobacteria, cyanobacteria, bacteroidetes, β-proteobacteria, and, less frequently, in α-, γ-, and δ-proteobacteria and other actinobacteria (192) . 
Biosynthesis of ERG
Functions of ERG
The role ERG plays in microbial cells is not well understood, but it does appear to have antioxidant and cytoprotectant properties in mammalian cells. In mammalian cells, the SLC22A4 gene encodes an integral membrane protein, the organic cation transporter (OCTN1) that facilitates Na + and pH-dependent transport of ERG across the membrane (193) . To account for the ubiquitous occurrence of ERG and its accumulation in tissues, various functions have been proposed for ERG: a cation chelator (194) (195) (196) , a factor in bioenergetics (197) , a regulator of gene expression (198) , an immune regulator (199) , and the most cited role as an antioxidant and cytoprotectant (200) (201) (202) (203) (204) . Although a large body of evidence demonstrates the antioxidant properties of ERG in vitro, Ey et al. (205) found that ERG only protected OCTN1-transfected HEK-293 against copper(II)-induced toxicity, but not against a range of other cellular stresses, although GSH at an equivalent concentration protected against all the cellular stresses tested. Yet, Kawano et al. (197) found that ERG accumulated in the mitochondria of hepatic cells of rats injected with radiolabeled ERG. In addition, Paul and Snyder (206) demonstrated increased mitochondrial DNA damage in OCTN1-silenced HeLa cells when exposed to H 2 O 2 .
In the case of microbes, an NcΔEgt-1 mutant in Neurospora crassa-involving a knockout in the gene NCU04343, which encodes a protein with fused domains that are homologous to M. avium EgtB and EgtD-does not produce ERG, in contrast to the wild type. NcΔEgt-1 was also found to be significantly more sensitive to tert-butyl hydroperoxide than the wild type. This suggested that ERG protects conidia from the toxicity of peroxide during the quiescent period between conidiogenesis and germination; however, similar protection was not observed with superoxide or Cu 2+ (207). Seebeck (179) indicated that homologues of M. smegmatis EgtB and EgtD are encoded in the genomes of most cyanobacteria, suggesting that ERG is involved in the protection of DNA against visible and UV radiation damage in cyanobacteria. Soil bacteria, such as M. smegmatis, could also benefit from this protection when exposed on the surface. Furthermore, the mshA mutant of M. smegmatis, which is deficient in mycothiol, was found to overproduce ERG by 35-fold in the exponential growth phase, possibly as a compensatory mechanism (208) . It is intriguing that mycobacteria have two redox intermediaries, although it is unknown if the production of either regulates the synthesis of the other redox buffer. However, they are unique in structure and have different redox properties, suggesting that they may play different roles in maintaining redox balance.
Tuberculosis and ERG
In 1956, it was reported that higher levels of ERG were found in the blood of Native Americans and Eskimos suffering from pulmonary tuberculosis than in "normal subjects" (209) . However, the "normal subjects" were sampled from two city hospitals where the Caucasian patients with tuberculosis were sampled. The Caucasian patients with pulmonary tuberculosis had mean ERG levels that were not significantly higher than those of the "normal subjects." Although the Native American diet was refuted as the cause of the unusually high ERG levels in the Native American and Eskimo patients, the "normal subjects" used as healthy controls were not from the same socioeconomic/racial group as the Native Americans and Eskimos with pulmonary tuberculosis, so that theoretically, the observations cannot be used to make an unbiased correlation with pulmonary tuberculosis.
In 2009, a genome-wide single nucleotide polymorphism (SNP)-based linkage analysis in 93 affected sibpairs identified chromosome 5q23.2-31.3 as a region with suggestive evidence of linkage with tuberculosis susceptibility in the Asian population (210) . Chromosome 5q31 contains the T helper 2 (Th2)-related cytokine gene cluster, which is potentially essential for the Th1/Th2 response. A family-based association analysis was used to fine-map a putative tuberculosis susceptibility locus in chromosome 5q23.2-31.3, and variants of a haplotype within the human gene SLC22A4, which codes for the ERG transporter OCTN1 (193) , were shown to be associated with tuberculosis susceptibility among the Thai population (211) .
MEASUREMENT OF THE REDOX STATE IN MYCOBACTERIA
All living organisms have protein thiols in the cytoplasm, which are kept in the reduced (-SH) state. Conventional methods used to measure the reduction potentials of NAD(P) + /NAD(P)H, GSH, ascorbate, thioredoxin, or thiol status in a cell involve enzymatic assays, spectroscopic methods, HPLC, or gel mobility that usually require whole-cell extracts. Cell disruption has little buffering capacity, creates oxidation artifacts, prevents dynamic measurements, and implies an apparent redox potential, which has low accuracy. They are also not amenable to multiple sample analyses and have no timedependent or spatial resolution (5, 6, 212, 213) . A further drawback of these invasive approaches is that the subcellular compartments often have different redox environments (5, 214, 215) . A noninvasive fluorescentbased method has been used to measure the intracellular thiol redox potential of E. coli involving a yellow fluorescent protein with a pair of redox-active cysteines introduced onto the surface of the protein (216) . The noninvasive measurement of the redox potential, −259 mV, was fairly comparable to the redox potential inferred by the redox-couple-specific approach, which was estimated to be within −220 to −245 mV (217) .
The intracellular redox environment of mycobacteria consists of known redox couples (218) and unknown redox couples, in addition to the combined intracellular protein thiol pool (6) . Although various methods have been used to quantify the mycothiol redox couple (MSH: MSS ratio) and ERG levels in mycobacteria, the intracellular redox potential of mycobacteria has not yet been determined.
MSH derivatization with monobromobimane (mBBr), followed by HPLC analysis, is the most widely used method for MSH detection (118, 146, 158, 161, 177, 178, 219) . However, this method failed to detect low quantities of ERG because the ERG moiety quenched the fluorescence of the bimane derivative, and the detection sensitivity was low. More recently, LC-MS/MS methods were used to quantify ERG in dietary sources (205) , human plasma and erythrocytes (220) , and MSH in the cell lysates of Mtr-deficient M. smegmatis mc 2 155 (221).
To date, the cellular redox ratio, reduced MSH:oxidized MSH (MSH:MSS), has been used to infer the redox status of the mycobacterial cell during different growth phases. In M. smegmatis mc 2 155, the redox ratio changes from 1,000:1 to 1,300:1 toward the end of lag phase to 200:1 in stationary phase (153, 161) . In M. tuberculosis Erdman, the redox ratio decreases from 180:1 at the end of lag phase to 50:1 in stationary phase (161) . The redox ratio of M. bovis BCG in stationary phase was also 50:1 (222). Ung and Av-Gay (222) also demonstrated a 2-fold decrease in the redox ratio of M. bovis BCG when treated with hydrogen peroxide, whereas the redox ratio of M. smegmatis mc 2 155 remained unchanged upon treatment with hydrogen peroxide, which may be explained by the higher reduced MSH levels present in M. smegmatis mc 
CONCLUSIONS AND FUTURE CHALLENGES
Control of redox pathways is crucial for bacteria, because redox homeostasis is central to metabolism and redistribution of cellular energy, ultimately controlling survival. What is the intrinsic redox and bioenergetic status of metabolically inactive M. tuberculosis, and how can this knowledge be exploited to devise new therapeutic intervention strategies? Unfortunately, to date, there are no clear answers to this question. M. tuberculosis is exposed to a wide spectrum of host redox stresses in vivo, including ROI, RNI, acidic pH, hypoxia, and nutrient deprivation, in addition to extraneous sources of redox imbalance such as cigarette smoke and indoor air pollution. Although there has been progress in the understanding of redox homeostasis in mycobacteria, the identity of all the main redox buffers and protein thiols, the behavior of these thiols and redox buffers under different environmental conditions, and all the intracellular mechanisms to maintain redox balance in M. tuberculosis are still unknown. Thus, it would be beneficial to define the M. tuberculosis "redoxome" using genomewide technologies. We also lack knowledge of how oxidative, nitrosative, and carbonyl stress modulate the metabolism and hence pathogenesis of M. tuberculosis. Using noninvasive redox-sensitive green fluorescent proteins, it should be possible to generate numerical indicators of the intracellular redox state of M. tuberculosis and monitor how these indicators change when mimicking the complex milieu of the lung, in particular in the presence or absence of O 2 , CO, and NO. Although mycothiol has been identified as a redox buffer in mycobacteria, the function of ERG in mycobacterial redox homeostasis and pathogenesis has yet to be elucidated. Furthermore, apart from known redox sensors in M. tuberculosis, such as the WhiB family members, DosS and DosT, σ factors, and thioredoxin-dependent redoxsensitive kinases, the redox sensors involved in reactivation of dormant bacilli have not yet been identified.
Redox homeostasis in mycobacteria also plays a role in drug efficacy, as isoniazid, ethionamide, and PA-824 require bioreductive activation for their antimycobacterial activity. However, our knowledge of the underlying mechanisms involved in this prodrug activation are largely unknown and would be of value in novel drug design. Likewise, treating latent M. tuberculosis infection requires a detailed knowledge of the physiology, and hence redox homeostasis, of the bacilli in response to their microenvironment, for instance, within the granuloma. Identification of terminal electron acceptors used in respiration of the mycobacteria and of mechanisms used to regenerate NAD(P)+ in this wide spectrum of microenvironments, together with the roles of CO, O 2 , and NO in altering mycobacterial respiration, is fundamental in understanding M. tuberculosis pathogenesis and persistence.
When in vitro models are used to study redox homeostasis, the observed mycobacterial response is in relation to the redox stressors and conditions present in the experimental setting. However, this is usually an incomplete representation of the response of mycobacteria in vivo, within the diseased niche. As mentioned earlier, M. tuberculosis is exposed to complex environments both in the macrophage and the lung, and it is anticipated that redox homeostasis within the bacillus will vary considerably in these diverse environments. In vivo murine TB models have been used to investigate the virulence and pathophysiology of M. tuberculosis or its mutants to ascertain the role of mycobacterial proteins or host proteins in pathogenesis and TB disease progression. Yet it has recently been shown, using genomic responses, that inflammatory responses in mouse models show poor correlation with human responses (223) . Thus, examining mycobacterial redox homeostasis within the varying environments of the human lung would ultimately give a more accurate, complete picture of how M. tuberculosis combats oxidative stress and subverts the host's immune response in order to establish persistence.
Comprehensive knowledge of the pathways involved in redox homeostasis in mycobacteria will give us a better understanding of the mechanisms whereby M. tuberculosis survives under diverse environmental extremes and induces pathogenesis, which will enable us to develop new therapeutic and infection control strategies.
